Review




Structured Review

Rotem Industries fibtem a10 11 mm extem a10 43 mm
(a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. <t>A10,</t> amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Fibtem A10 11 Mm Extem A10 43 Mm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/a10+assay+clauss+fibrinogen+fibtem+%E2%80%A2/pmc12982010-58-1-0
Average 86 stars, based on 1 article reviews
fibtem a10 11 mm extem a10 43 mm - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department"

Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department

Journal: Vox Sanguinis

doi: 10.1111/vox.70167

(a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Figure Legend Snippet: (a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Techniques Used: Coagulation, FIBTEM Assay, Lysis

(a) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in rotational thromboelastometry (ROTEM) ( n = 397). (b) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in thromboelastogram (TEG) ( n = 41). A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Figure Legend Snippet: (a) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in rotational thromboelastometry (ROTEM) ( n = 397). (b) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in thromboelastogram (TEG) ( n = 41). A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Techniques Used: Coagulation, FIBTEM Assay, Lysis

Concordance of fibrinogen, platelet and coagulation factor deficiencies detected by viscoelastic haemostatic assay (VHA) and conventional coagulation test (CCT) in paired samples ( n = 120). Rotational thromboelastometry (ROTEM) and thromboelastogram (TEG) were combined. Definitions: Fibrinogen—ROTEM: Fibrin‐based thromboelastometry (FIBTEM) amplitude 10 min after start of clotting time (CT) (A10) <11 mm; TEG: citrated functional fibrinogen (CFF) maximum amplitude (MA) <15 mm; CCT: Fibrinogen <1.0 g/L. Platelet—ROTEM: FIBTEM A10 ≥11 mm + extrinsically activated thromboelastometry (EXTEM) A10 <43 mm; TEG: CFF MA ≥15 mm + clot reaction time (CRT) MA <50 mm; CCT: Platelets <50 × 10 9 /L. Coagulation factor—ROTEM: EXTEM CT >80 s; TEG: Clotting time (R‐time) in citrated kaolin channel of TEG 6s (CK R) > 9 min; CCT: international normalized ratio (INR) >1.5.
Figure Legend Snippet: Concordance of fibrinogen, platelet and coagulation factor deficiencies detected by viscoelastic haemostatic assay (VHA) and conventional coagulation test (CCT) in paired samples ( n = 120). Rotational thromboelastometry (ROTEM) and thromboelastogram (TEG) were combined. Definitions: Fibrinogen—ROTEM: Fibrin‐based thromboelastometry (FIBTEM) amplitude 10 min after start of clotting time (CT) (A10) <11 mm; TEG: citrated functional fibrinogen (CFF) maximum amplitude (MA) <15 mm; CCT: Fibrinogen <1.0 g/L. Platelet—ROTEM: FIBTEM A10 ≥11 mm + extrinsically activated thromboelastometry (EXTEM) A10 <43 mm; TEG: CFF MA ≥15 mm + clot reaction time (CRT) MA <50 mm; CCT: Platelets <50 × 10 9 /L. Coagulation factor—ROTEM: EXTEM CT >80 s; TEG: Clotting time (R‐time) in citrated kaolin channel of TEG 6s (CK R) > 9 min; CCT: international normalized ratio (INR) >1.5.

Techniques Used: Coagulation, FIBTEM Assay, Functional Assay

Related Articles

other:

Article Title: Point-of-Care Hemostatic Testing in Cardiac Surgery
Article Snippet: ROTEM measures included A10-EXTEM (clot amplitude at 10 min with the ROTEM extrinsic pathway assay: < 35 mm implies impaired clot formation due to low fibrinogen levels, low platelet count, or impaired platelet function); A10FIBTEM (clot firmness amplitude at 10 min with ROTEM fibrinogen assay: 8 mm confirms low fibrinogen levels); and CT-EXTEM (clotting time with ROTEM extrinsic pathway assay: 90 s implied poor clot initiation possibly due to reduced coagulation factor levels or reduced thrombin generation).



Similar Products

86
Rotem Industries fibtem a10 11 mm extem a10 43 mm
(a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. <t>A10,</t> amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Fibtem A10 11 Mm Extem A10 43 Mm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/a10+assay+clauss+fibrinogen+fibtem+%E2%80%A2/pmc12982010-58-1-0
Average 86 stars, based on 1 article reviews
fibtem a10 11 mm extem a10 43 mm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Rotem Industries extem a10
(a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. <t>A10,</t> amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Extem A10, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/a10+assay+clauss+fibrinogen+fibtem+%E2%80%A2/pm41125237-2649-7-18
Average 86 stars, based on 1 article reviews
extem a10 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Rotem Industries rotem extem a10
Number of <t>rotational</t> <t>thromboelastometry</t> <t>(ROTEM)</t> abnormalities per patient on first ROTEM read across cohort ( N = 446).
Rotem Extem A10, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/a10+assay+clauss+fibrinogen+fibtem+%E2%80%A2/pmc12432809-53-0-0
Average 86 stars, based on 1 article reviews
rotem extem a10 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Rotem Industries rotem® delta ∆a10 (extem minus fibtem)
Rotem® and Multiplate® results in ICU patients (total n = 18)
Rotem® Delta ∆A10 (Extem Minus Fibtem), supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/rotem++delta+%E2%88%86a10++extem+minus+fibtem+/pmc08170428-33-0-0
Average 90 stars, based on 1 article reviews
rotem® delta ∆a10 (extem minus fibtem) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Rotem Industries a10 extem
Rotem® and Multiplate® results in ICU patients (total n = 18)
A10 Extem, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/rotem+extem/pmc06944942-130-6-11
Average 90 stars, based on 1 article reviews
a10 extem - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health extem a10
Rotem® and Multiplate® results in ICU patients (total n = 18)
Extem A10, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/extem+a10/pm29554045-115-0-29
Average 90 stars, based on 1 article reviews
extem a10 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Rotem Industries rotem®-extem-a10
Rotem® and Multiplate® results in ICU patients (total n = 18)
Rotem® Extem A10, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/rotem+extem+ct/pm28831518-190-10-19
Average 90 stars, based on 1 article reviews
rotem®-extem-a10 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Rotem Industries rotem®-extem-a10 ≥ 45mm
Rotem® and Multiplate® results in ICU patients (total n = 18)
Rotem® Extem A10 ≥ 45mm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/rotem++extem+a10+++45mm/pm28831518-139-32-33
Average 90 stars, based on 1 article reviews
rotem®-extem-a10 ≥ 45mm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Rotem Industries a10-extem
Rotem® and Multiplate® results in ICU patients (total n = 18)
A10 Extem, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a10-extem/rotem+extem/10__1161_slash_circulationaha__116__023956-228-3-11
Average 90 stars, based on 1 article reviews
a10-extem - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


(a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Journal: Vox Sanguinis

Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department

doi: 10.1111/vox.70167

Figure Lengend Snippet: (a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Article Snippet: ROTEM: FIBTEM A10 ≥ 11 mm + EXTEM A10 < 43 mm , 45 (11.3%) , 3 (7.3%).

Techniques: Coagulation, FIBTEM Assay, Lysis

(a) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in rotational thromboelastometry (ROTEM) ( n = 397). (b) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in thromboelastogram (TEG) ( n = 41). A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Journal: Vox Sanguinis

Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department

doi: 10.1111/vox.70167

Figure Lengend Snippet: (a) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in rotational thromboelastometry (ROTEM) ( n = 397). (b) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in thromboelastogram (TEG) ( n = 41). A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.

Article Snippet: ROTEM: FIBTEM A10 ≥ 11 mm + EXTEM A10 < 43 mm , 45 (11.3%) , 3 (7.3%).

Techniques: Coagulation, FIBTEM Assay, Lysis

Concordance of fibrinogen, platelet and coagulation factor deficiencies detected by viscoelastic haemostatic assay (VHA) and conventional coagulation test (CCT) in paired samples ( n = 120). Rotational thromboelastometry (ROTEM) and thromboelastogram (TEG) were combined. Definitions: Fibrinogen—ROTEM: Fibrin‐based thromboelastometry (FIBTEM) amplitude 10 min after start of clotting time (CT) (A10) <11 mm; TEG: citrated functional fibrinogen (CFF) maximum amplitude (MA) <15 mm; CCT: Fibrinogen <1.0 g/L. Platelet—ROTEM: FIBTEM A10 ≥11 mm + extrinsically activated thromboelastometry (EXTEM) A10 <43 mm; TEG: CFF MA ≥15 mm + clot reaction time (CRT) MA <50 mm; CCT: Platelets <50 × 10 9 /L. Coagulation factor—ROTEM: EXTEM CT >80 s; TEG: Clotting time (R‐time) in citrated kaolin channel of TEG 6s (CK R) > 9 min; CCT: international normalized ratio (INR) >1.5.

Journal: Vox Sanguinis

Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department

doi: 10.1111/vox.70167

Figure Lengend Snippet: Concordance of fibrinogen, platelet and coagulation factor deficiencies detected by viscoelastic haemostatic assay (VHA) and conventional coagulation test (CCT) in paired samples ( n = 120). Rotational thromboelastometry (ROTEM) and thromboelastogram (TEG) were combined. Definitions: Fibrinogen—ROTEM: Fibrin‐based thromboelastometry (FIBTEM) amplitude 10 min after start of clotting time (CT) (A10) <11 mm; TEG: citrated functional fibrinogen (CFF) maximum amplitude (MA) <15 mm; CCT: Fibrinogen <1.0 g/L. Platelet—ROTEM: FIBTEM A10 ≥11 mm + extrinsically activated thromboelastometry (EXTEM) A10 <43 mm; TEG: CFF MA ≥15 mm + clot reaction time (CRT) MA <50 mm; CCT: Platelets <50 × 10 9 /L. Coagulation factor—ROTEM: EXTEM CT >80 s; TEG: Clotting time (R‐time) in citrated kaolin channel of TEG 6s (CK R) > 9 min; CCT: international normalized ratio (INR) >1.5.

Article Snippet: ROTEM: FIBTEM A10 ≥ 11 mm + EXTEM A10 < 43 mm , 45 (11.3%) , 3 (7.3%).

Techniques: Coagulation, FIBTEM Assay, Functional Assay

Number of rotational thromboelastometry (ROTEM) abnormalities per patient on first ROTEM read across cohort ( N = 446).

Journal: Transfusion

Article Title: Adherence to local rotational thromboelastometry recommendations in the care of trauma patients: A retrospective cohort study

doi: 10.1111/trf.18349

Figure Lengend Snippet: Number of rotational thromboelastometry (ROTEM) abnormalities per patient on first ROTEM read across cohort ( N = 446).

Article Snippet: ROTEM EXTEM A10, mean (SD) , 51.13 (11.79) , 56.47 (7.39) , 46.43 (12.96) , 0.952.

Techniques:

Rotem® and Multiplate® results in ICU patients (total n = 18)

Journal: Thrombosis Journal

Article Title: Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study

doi: 10.1186/s12959-021-00293-8

Figure Lengend Snippet: Rotem® and Multiplate® results in ICU patients (total n = 18)

Article Snippet: Rotem® Delta ∆A10 (EXTEM minus FIBTEM) [mm] ∆MCF (EXTEM minus FIBTEM) [mm] , 33 (27–36) 36 (29–37) , 24 (19–35) 29 (22–36) , 29 (23–33) 28 (23–35) , 30 (24–36) 33 (25–40).

Techniques: FIBTEM Assay

Platelet aggregation ability by Multiplate®. Correlation between ∆A10 (EXTEM minus FIBTEM) and platelet count, mean platelet volume and platelet aggregation ability (Multiplate® with TRAP-6 and ADP). a ∆A10 vs. platelet count. b ∆A10 vs. mean platelet volume. c ∆A10 vs. Multiplate® with agonist TRAP-6. d ∆A10 vs. Multiplate® with agonist ADP. Values are presented during the course of ICU stay for day 1 (●), day 4 (■), day 7 (▲) and day 14 (▼) respectively. Spearman correlation coefficient is displayed by r s . Reference values for platelet count, mean platelet volume, TRAP-6 and ADP are indicated by pink boxes

Journal: Thrombosis Journal

Article Title: Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study

doi: 10.1186/s12959-021-00293-8

Figure Lengend Snippet: Platelet aggregation ability by Multiplate®. Correlation between ∆A10 (EXTEM minus FIBTEM) and platelet count, mean platelet volume and platelet aggregation ability (Multiplate® with TRAP-6 and ADP). a ∆A10 vs. platelet count. b ∆A10 vs. mean platelet volume. c ∆A10 vs. Multiplate® with agonist TRAP-6. d ∆A10 vs. Multiplate® with agonist ADP. Values are presented during the course of ICU stay for day 1 (●), day 4 (■), day 7 (▲) and day 14 (▼) respectively. Spearman correlation coefficient is displayed by r s . Reference values for platelet count, mean platelet volume, TRAP-6 and ADP are indicated by pink boxes

Article Snippet: Rotem® Delta ∆A10 (EXTEM minus FIBTEM) [mm] ∆MCF (EXTEM minus FIBTEM) [mm] , 33 (27–36) 36 (29–37) , 24 (19–35) 29 (22–36) , 29 (23–33) 28 (23–35) , 30 (24–36) 33 (25–40).

Techniques: FIBTEM Assay

Typical examples of Rotem® INTEM, EXTEM and FIBTEM measurements for a COVID-19 ARDS patient and a healthy control. Typical examples of Rotem® INTEM, EXTEM and FIBTEM measurements for a COVID-19 ARDS patient and a healthy control. Units are displayed in square brackets and reference values in round brackets. Abnormal values are presented in red. Abbreviations: Clotting Time (CT), Clot Formation Time (CFT), Amplitude 10 min after CT (A10), Maximum Clot Firmness (MCF), Lysis Index 30 min (LI30).

Journal: Thrombosis Journal

Article Title: Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study

doi: 10.1186/s12959-021-00293-8

Figure Lengend Snippet: Typical examples of Rotem® INTEM, EXTEM and FIBTEM measurements for a COVID-19 ARDS patient and a healthy control. Typical examples of Rotem® INTEM, EXTEM and FIBTEM measurements for a COVID-19 ARDS patient and a healthy control. Units are displayed in square brackets and reference values in round brackets. Abnormal values are presented in red. Abbreviations: Clotting Time (CT), Clot Formation Time (CFT), Amplitude 10 min after CT (A10), Maximum Clot Firmness (MCF), Lysis Index 30 min (LI30).

Article Snippet: Rotem® Delta ∆A10 (EXTEM minus FIBTEM) [mm] ∆MCF (EXTEM minus FIBTEM) [mm] , 33 (27–36) 36 (29–37) , 24 (19–35) 29 (22–36) , 29 (23–33) 28 (23–35) , 30 (24–36) 33 (25–40).

Techniques: FIBTEM Assay, Control, Coagulation, Lysis